Monday, October 23, 2017

Dyadic…Understanding the Value Proposition of C1 and the Stock

Last Friday, Dyadic CEO, Mark Emalfarb, gave an online investor presentation at a Virtual Investors Conference. The presentation was well done in that it...
video

Dyadic CEO Interview

Mark Emalfarb, the Chairman and CEO of Dyadic International, discusses the status of the  Company's revolutionary C1 protein expression host.

Can Dyadic Reduce the Costs of Biologics?

Dyadic International is a progressive and interesting company in more ways than one. Founded by Mark Emalfarb in 1979, this commercially proven gene expression...

Dyadic Announces $5 Million Stock Repurchase Program

JUPITER, Fla., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (DYAI) (“Dyadic”) announced that its Board of Directors has authorized a new stock...

Adding Dyadic (DYAI) to The Tailwinds Select Portfolio

On Friday, August 4, 2017, we added Dyadic International (DYAI) to The Tailwinds Select Portfolio at a price of $1.34 per share. Dyadic International, Inc....

Dyadic Announces Multi-Year R&D Arrangement to Further Advance Its Proprietary C1 Technology

UPITER, FL – July 10, 2017 (GLOBE NEWSWIRE) – Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), announced today that it has entered into a comprehensive series...

Dyadic Announces $7.4 Million Released From Escrow

UPITER, FL – July 6, 2017 (GLOBE NEWSWIRE) – Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), is pleased to announce that it has received approximately $7.4...

Dyadic Announces Board Member Share Purchases

JUPITER, FL – May 25, 2017 (GLOBE NEWSWIRE) – Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), announced today that its Chairman of the Board, Michael P. Tarnok,...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address